Clinical trial Recruiting at 1 site Observational Ages 60 and up

Elderly Hip Fracture Cohort Across China

Official title: Cohort Study on the Prognosis and Influencing Factors in Elderly Patients With Hip Fractures in Multicenter of China

Run by Beijing Hospital · NCT07847164 · Data updated 2026-11-12

This large, multicenter cohort study will follow Chinese adults aged 60 and older with hip fractures to look at prognosis and factors that affect outcomes.

Quick facts

Study typeObservational
Ages60 Years and up
SexAll
Enrollment10000 (estimated)
SponsorBeijing Hospital
Government
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedDecember 1, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedSeptember 29, 2026
Trial IDNCT07847164 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Candidates are adults aged 60 years or older with a radiographically confirmed hip fracture who were hospitalized for treatment after September 1, 2022 and can consent.

Probably not a fit

Patients with pathological fractures from tumors or bone development disorders, peri-implant fractures, or those not deemed eligible by investigators may not benefit from this study's findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will enroll elderly patients with hip fractures from 38 hospitals across China and collect standardized baseline data, medical history, genetics, imaging, and treatment details. Participants will be followed for 1 to 2 years to monitor survival, re-fractures, comorbidities, complications, and post-discharge care. The project aims to create a national, multicenter cohort database to support prognostic research and improve future care pathways for geriatric hip fractures. Data will come from both surgical and non-surgical management, with emphasis on unified inclusion criteria and systematic follow-up. No interventional procedures are described within the protocol.

Why it matters

Potential benefit: If successful, the cohort could clarify prognosis and risk factors, helping tailor prevention and treatment strategies for elderly hip fracture patients.

How similar studies have gone: Previous multicenter registries have shown value in prognosis research for osteoporotic fractures, but this project focuses on building a national, standardized cohort in China, which is relatively novel for this condition.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:1: The subjects are of Chinese nationality.

2: The subject is 60 years of age or older (including the boundary value)

3:The subject has been diagnosed with hip fracture by imaging, including femoral neck fracture, intertrochanteric fracture of femur, and subtrochanteric fracture of femur

4: Patients who were hospitalized for hip fracture treatment (surgical or conservative) after September 1, 2022

5: The subject can fully understand and sign the informed consent form.

\-

Exclusion Criteria:1: Pathological fractures caused by primary or metastatic tumors of bone or bone developmental disorders

2: Patients with peri-implant fractures or polytrauma (multiple injuries resulting from a single traumatic event in which two or more anatomical sites in the body are severely injured, with one of them being severely injured even in the absence of the traumatic event also posing a life-threatening risk)

3: Subjects who, in the opinion of the investigator, are not eligible for enrollment in the study.

\-

Where it's running

  • Beijing Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.